News & Updates
Showing Hepatology articles
Showing
Show Multimedia Only

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
13 Feb 2024
byAudrey Abella
In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.
13 Feb 2024

Noncontrast-enhanced MRI superior to US but less cost-effective for HCC screening
31 Jan 2024
byStephen Padilla
Noncontrast-enhanced magnetic resonance imaging (NCEMRI) demonstrates superiority over ultrasonography (US) for the surveillance of hepatocellular carcinoma (HCC) in at-risk populations, although this strategy is more expensive than US, according to a Singapore study.
31 Jan 2024

Vaccines protect liver disease patients against severe COVID-19
20 Jan 2024
byStephen Padilla
Patients with liver disease develop antibodies and T-cell responses following three shots of COVID-19 vaccines, while those who have been infected with SARS-CoV-2 develop mild symptoms only, reports a recent study.
20 Jan 2024





